Sudard SP

Sudard SP is an oral fixed-dose combination tablet developed by Anglo-French Drugs & Industries, primarily indicated for the relief of pain, inflammation, and inflammatory edema associated with conditions such as arthritis, trauma, sprains, pelvic inflammatory disease, and post-operative or dental procedures. The formulation typically contains aceclofenac (a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes COX-1 and COX-2), paracetamol (an analgesic and antipyretic), and serratiopeptidase (a proteolytic enzyme that breaks down abnormal proteins and fibrin at inflammatory sites to reduce swelling and promote tissue repair). Some regional listings also report a formulation containing diclofenac instead of aceclofenac. Together, these components work synergistically to alleviate moderate pain, reduce fever, and accelerate the resolution of inflammatory edema.

Brand names

Sudard SP

Other names

aceclofenac + paracetamol + serratiopeptidasediclofenac + paracetamol + serratiopeptidase